Full approval of the Covid vaccine in the United States could lead to more workplace obligations, but it is unlikely to change the minds of those who no longer want injections, Dr. Scott ottlieb I told CNBC on Wednesday.
“This can be a turning point, and for some people it can increase the incentive to go out and get vaccinated,” Gottlieb said.Squawk Box“But I don’t think it actually promotes many additional vaccinations among those who have been hesitant to vaccinate.”
The FDA has raised its schedule to fully approve the double-dose Pfizer-BioNTech vaccination, According to the New York Times.. The informal deadline for US regulators is Labor Day or earlier, according to sources spoken to The Times.
Gottlieb said he expected a two-shot Modana Vaccines that follow quickly.The only other vaccine approved for emergency use authorization in the United States Johnson & JohnsonSingle dose regimen. J & J has not yet applied for full approval.
Former FDA Chief and Present Pfizer Board members acknowledged that many studies indicate a lack of complete approval as a reason for vaccine hesitation. But he said he doesn’t think people care so much that surveyors believe in full approval when compared to their current EUA status.
“In reality, these vaccines have been used by hundreds of millions of people at this point,” Gottlieb said. “At this point there was a huge dataset and from a review point of view the EUA was … equivalent to a full BLA, a full biological license application, so I’m not sure if this makes such a distinction. Hmm. In the hearts of many consumers. “
about 70% of adults in the United States have at least one shot According to the Covid-19 vaccine, which is fully vaccinated by about 49.7% of all Americans. CDC data..
Mayor of New York to combat the epidemic of highly contagious delta mutants and promote immunization Bill de Blasio On Tuesday, it was announced that vaccines would be mandatory for various indoor venues scheduled to take effect on August 16. Full enforcement will begin in mid-September.
Gottlieb supported the move, emphasizing that crowded cities “have to think differently about the risks that prevail at meetings.”
Full FDA approval gives employers greater incentives to demand vaccinations in the workplace, Gottlieb said. Donald TrumpPresident.
Disclosure: Scott Gottlieb is a CNBC contributor and member of the board of directors of Pfizer, genetic testing startup Tempus, healthcare technology company Aetion Inc., and biotechnology company Illumina. He is also Co-Chair of Norwegian Cruise Line Holdings and Royal Caribbean’s “Healthy Sail Panel”.
Dr. Scott Gottlieb says full approval of the Covid vaccine is unlikely to persuade Americans to hesitate.
Source link Dr. Scott Gottlieb says full approval of the Covid vaccine is unlikely to persuade Americans to hesitate.